Dimensional Fund Advisors
HZNP

Dimensional Fund Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Dimensional Fund Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-829,634
Closed -$96M – 3510
2023
Q3 		$96M Sell
829,634
-150,465
-15% -$16.2M 0.03% 833
2023
Q2 		$101M Sell
980,099
-31,560
-3% -$3.33M 0.03% 837
2023
Q1 		$110M Buy
1,011,659
+3,434
+0.3% +$380K 0.04% 714
2022
Q4 		$115K Sell
1,008,225
-10,616
-1% -$882K 0.03% 679
2022
Q3 		$63.1M Buy
1,018,841
+15,484
+2% +$1.08M 0.02% 1034
2022
Q2 		$80M Sell
1,003,357
-137,251
-12% -$13M 0.03% 906
2022
Q1 		$120M Buy
1,140,608
+13,680
+1% +$1.33M 0.04% 702
2021
Q4 		$121M Sell
1,126,928
-214,661
-16% -$23.4M 0.04% 716
2021
Q3 		$147M Sell
1,341,589
-48,739
-4% -$5.06M 0.05% 529
2021
Q2 		$130M Buy
1,390,328
+5,135
+0.4% +$473K 0.04% 625
2021
Q1 		$127M Sell
1,385,193
-270,045
-16% -$22.8M 0.04% 618
2020
Q4 		$121M Sell
1,655,238
-844,550
-34% -$62.8M 0.04% 585
2020
Q3 		$194M Sell
2,499,788
-1,141,639
-31% -$78.6M 0.08% 212
2020
Q2 		$202M Sell
3,641,427
-559,961
-13% -$24M 0.09% 178
2020
Q1 		$124M Sell
4,201,388
-480,575
-10% -$16.3M 0.06% 280
2019
Q4 		$169M Sell
4,681,963
-204,910
-4% -$6.28M 0.06% 353
2019
Q3 		$133M Buy
4,886,873
+98,911
+2% +$2.56M 0.05% 465
2019
Q2 		$115M Sell
4,787,962
-212,308
-4% -$5.39M 0.04% 565
2019
Q1 		$132M Sell
5,000,270
-140,297
-3% -$3.32M 0.05% 444
2018
Q4 		$100M Sell
5,140,567
-182,023
-3% -$3.57M 0.05% 545
2018
Q3 		$104M Sell
5,322,590
-96,981
-2% -$1.84M 0.04% 668
2018
Q2 		$89.7M Sell
5,419,571
-700,106
-11% -$10.7M 0.04% 751
2018
Q1 		$86.9M Sell
6,119,677
-671,956
-10% -$9.93M 0.04% 726
2017
Q4 		$99.2M Sell
6,791,633
-641,697
-9% -$9.01M 0.04% 631
2017
Q3 		$94.3M Buy
7,433,330
+1,167,722
+19% +$14.8M 0.04% 629
2017
Q2 		$74.4M Buy
6,265,608
+3,409,411
+119% +$42.4M 0.03% 782
2017
Q1 		$42.2M Buy
2,856,197
+264,592
+10% +$4.29M 0.02% 1365
2016
Q4 		$41.9M Buy
2,591,605
+626,300
+32% +$11.4M 0.02% 1325
2016
Q3 		$35.6M Buy
1,965,305
+506,785
+35% +$9.9M 0.02% 1414
2016
Q2 		$24M Buy
1,458,520
+891,466
+157% +$14.4M 0.01% 1692
2016
Q1 		$9.39M Buy
567,054
+9,282
+2% +$162K 0.01% 2235
2015
Q4 		$12.1M Buy
557,772
+284,359
+104% +$5.54M 0.01% 2114
2015
Q3 		$5.41M Buy
273,413
+80,630
+42% +$2.55M ﹤0.01% 2485
2015
Q2 		$6.7M Buy
+192,783
New +$5.88M ﹤0.01% 2448
2015
Q1 		– Sell
-9,021
Closed -$116K – 3430
2014
Q4 		$116K Buy
+9,021
New +$113K ﹤0.01% 3306
2014
Q3 		– Sell
-190,470
Closed -$3.01M – 3575
2014
Q2 		$3.01M Sell
190,470
-8,000
-4% -$114K ﹤0.01% 2737
2014
Q1 		$3M Buy
198,470
+767
+0.4% +$8.66K ﹤0.01% 2738
2013
Q4 		$1.51M Buy
197,703
+4,265
+2% +$23K ﹤0.01% 2924
2013
Q3 		$654K Buy
193,438
+4,688
+2% +$12.4K ﹤0.01% 3130
2013
Q2 		$464K Buy
+188,750
New +$453K ﹤0.01% 3196

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Dimensional Fund Advisors's HZNP Position: Q4 2023 in Review

Dimensional Fund Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 829,634 shares — an estimated $96M sold.

Dimensional Fund Advisors first reported a position in HZNP in Q2 2013 and held it in 40 quarters. The position peaked at $202M in Q2 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Dimensional Fund Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 829,634 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $96M.
  • Dimensional Fund Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 40 quarters.
  • Dimensional Fund Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $202M in Q2 2020.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Dimensional Fund Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.